Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
Journal of Infection and Public Health. 2014; 7 (3): 233-236
in English | IMEMR | ID: emr-141905

ABSTRACT

Features of low tension in breast hydatid cyst and symptoms secondary to cyst dying and disintegration are unique and not yet reported in the literature. An young woman of 30 years complained about pain and vague swelling in the right breast during follow-up with albendazole therapy following second laparotomy for post-surgical residual cavity of hydatid cyst in the left lobe of the liver. Breast ultrasound was diagnostic. Segmental breast excision revealed a large dead hydatid cyst. Postoperative course was uneventful. Breast hydatid cyst may become symptomatic and hypotensive after start of albendazole therapy


Subject(s)
Humans , Female , Breast Diseases/diagnosis , Albendazole , Echinococcus granulosus
2.
Saudi Medical Journal. 2008; 29 (4): 580-583
in English | IMEMR | ID: emr-100322

ABSTRACT

To diagnose isolated tuberculosis of the sternum in patients presenting with signs and symptoms suggestive of tuberculosis. A prospective study conducted at Jawaharlal Nehru Medical College [JNMC] Hospital, Aligarh, India from July 2000 to July 2006 of 2512 patients presenting with a suspected case of tuberculosis. Cases were confirmed using different investigations along with treatment of the patients with antitubercular treatment [ATT], with further follow up for next 2 years. Nineteen patients were suffering from isolated tuberculosis of sternum. The main presenting feature was retrosternal discomfort [100%] while 14 [73.6%] patients presented with a cold abscess of sternum. All the patients were treated successfully with 12 months of ATT and followed up for 2 years for any relapse. Although tuberculosis of sternum is rare, it should be considered as an important differential diagnosis in patients presenting with chronic lesions of the sternum, particularly in endemic/developing countries. Twelve months of treatment with ATT is optimal for achieving cure without any risk of relapse


Subject(s)
Humans , Male , Female , Sternum , Antitubercular Agents , Tuberculosis, Osteoarticular/drug therapy , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL